Henry C. MARSH

City:

Reading, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-02-20

Top Assignees for applications by Henry C. MARSH

The entities that hold a legal rights for patent applications filed by inventor MARSH Henry C.:

CELLDEX THERAPEUTICS, INC. 5 Needham, MA United States
UNIVERSITY OF IOWA RESEARCH FOUNDATION 2 Iowa City, IA United States
CELLDEX THERAPEUTICS, INC. 1 Hampton, NJ United States

Recent patent applications by MARSH Henry C.

Henry C. MARSH from Reading, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-20

US20250059291A1

Chemistry; metallurgy

CD27 AGONISTS

#2 | 2023-11-09

US20230355673A1

Human necessities

CHIMERIC ANTIGEN RECEPTORS TARGETING TIM-1

#3 | 2022-07-21

US20220227877A1

Chemistry; metallurgy

ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF

#4 | 2018-02-15

US20180044429A1

Chemistry; metallurgy

CD27 AGONISTS

#5 | 2016-06-30

US20160184392A1

Human necessities

Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)

#6 | 2015-11-26

US20150337047A1

Chemistry; metallurgy

Antibodies that bind human CD27 and uses thereof

#7 | 2012-08-23

US20120213771A1

Chemistry; metallurgy

ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF

#8 | 2012-03-22

US20120071413A1

Human necessities

Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)

#9 | 2011-11-10

US20110274685A1

Chemistry; metallurgy

Antibodies that bind human CD27 and uses thereof

#10 | 2010-05-27

US20100130413A1

Human necessities

Treatment for age-related macular degeneration and other diseases of the eye

InventorID:

1367700 ⎘